Kyoei Steel Ltd. (TYO:5440)

Market Cap	95.04B
Revenue (ttm)	318.71B
Net Income (ttm)	10.88B
Shares Out	43.46M
EPS (ttm)	250.42
PE Ratio	8.73
Forward PE	7.50
Dividend	90.00 (4.14%)
Ex-Dividend Date	Sep 29, 2025

Volume	15,500
Average Volume	98,270
Open	2,187.00
Previous Close	2,187.00
Day's Range	2,187.00 - 2,211.00
52-Week Range	1,588.00 - 2,284.00
Beta	0.45
RSI	55.65
Earnings Date	Jul 31, 2025

About Ligand Pharmaceuticals

Kyoei Steel Ltd. engages in the manufacture, processing, and sells of billets and steel products in Japan, Vietnam, North America, and internationally. The company operates through three segments: Domestic Steel Business, Overseas Steel Business, and Material Recycling Business. It offers concrete reinforcing bars; merchant bars, such as flat bars, I beams, equal angle bars, and round bars; billets; and threaded rebars and joints for threaded rebars. The company is also involved in the collection, transportation, and treatment of general, indus...

• Industry: Steel
• Sector: Materials
• Founded: 1947
• Employees: 3,903
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 5440

Financial Performance

In 2024, Kyoei Steel's revenue was 322.85 billion, an increase of 0.58% compared to the previous year's 320.98 billion. Earnings were 10.79 billion, a decrease of -21.95%.